-
FDA Grants Clearance for UltraSight’s AI-Powered Cardiac Ultrasound Technology
New AI guidance software will allow more medical professionals to conduct cardiac ultrasound in multiple care settings expanding patient access to cardiac imaging TEL AVIV, Israel, July 27, 2023 — Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced that it has been granted FDA clearance for its AI-powered ultrasound guidance […]
-
UltraSight and EchoNous Partner to Enable More Accessible Cardiac Ultrasound for Patients
New partnership to bring the benefits of cardiac imaging to new healthcare settings NATIONAL HARBOR, MD., June 23, 2023 – Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access […]
-
UltraSight Granted Patent for Real-Time Guidance Ultrasound Technology
OnSight Wins TCT connect 2020 Shark Tank Innovation Competition
-
New Landmark Study Indicates UltraSight Enables Novice Ultrasound Users to Capture High Quality Cardiac Images
Findings confirm diagnostic echocardiographic exams can be performed by medical professionals without sonography experience by using UltraSight TEL AVIV, Israel, Nov. 28, 2022 — UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, today announced new findings from a landmark pivotal study. According to the results, UltraSight’s AI guidance and quality […]
-
UltraSight Receives CE Mark for Novel Cardiac AI Technology
UltraSight Selected to Conduct a Study Onboard the International Space Station
-
New Study Reveals UltraSight & Sheba Medical Center Enable Novice Ultrasound Users to Obtain Accurate, Diagnostic Quality Cardiac Images
Images acquired with AI guidance software deemed usable in 100 percent of cardiac patients TEL AVIV, Israel, May 26, 2022 — At the 69th Annual Conference of the Israel Heart Society, UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, and Sheba Medical Center Israel revealed new research findings from a blinded pilot study that […]
-
UltraSight Announces Appointment of Dr. Ruth Atherton, JD to Board of Directors
Expansion of board signals digital health company’s growth and increased focus on creating access to cardiac ultrasound TEL AVIV, Israel, May 3, 2022 — UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, is proud to announce that Ruth Atherton, PhD, JD, has joined its board of directors. Dr. Atherton has a […]
-
UltraSight Collaboration with GE Healthcare will bring Wireless Cardiac Point of Care Ultrasound to Space
Technology developed through partnership to monitor astronaut’s heart during ‘Rakia’ space mission CHICAGO and TEL AVIV, ISRAEL, Sept. 30, 2021 — UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI, announced a new collaboration with GE Healthcare to conduct a cardiac study aboard the Axiom ‘Rakia’ space mission, and the successful completion of Preliminary Design Review (PDR) […]
-
UltraSight Raises $13 million to Bring AI Guidance for Cardiac Ultrasound to Patient Point of Care
Digital Health company transforming ultrasound industry TEL AVIV, Israel, May 11, 2021 — UltraSight (formerly OnSight Medical), a Digital Health pioneer for cardiac imaging and beyond, announced today that it has closed a $13 million Series B funding round. The investment will be used to advance U.S. clinical programs for its real time, AI guidance in a variety of care […]
